Description:
These sessions illustrate the advantages of integrating fundamental design concepts into process development to support pharmaceutical manufacturing, with an emphasis on scale-up considerations and case studies. Drug substance and drug product applications are both considered for this session track. Contributions that incorporate process modeling with experimental designs to optimize product performance in drug substance and/or drug product are encouraged for submission. Modeling approaches including CFD, DEM, FEM, PBM, Monte Carlo and other methods, or a focus on thermodynamic, kinetic and transport parameter estimation, are welcomed.
Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Pharmaceuticals (15B)
Chair:
Mary T. am Ende
Research Fellow
Worldwide Research and Development, Pfizer Inc.
445 Eastern Point Road
Groton, CT
06340
Email: mary.t.am.ende@pfizer.com
Research Fellow
Worldwide Research and Development, Pfizer Inc.
445 Eastern Point Road
Groton, CT
06340
Email: mary.t.am.ende@pfizer.com
Co-chairs:
Michael L. Hoffman
Abbvie Laboratories
100 Abbott Park Road
Abbott Park, IL
60064-3500
Email: Michael.Hoffman@abbvie.com
Mehrdad Kheiripour
Manager
Neurocrine Biosciences Inc
Process Design & Engineering
160 Convent Avenue
10031
Email: mkheiripour@neurocrine.com
Abbvie Laboratories
100 Abbott Park Road
Abbott Park, IL
60064-3500
Email: Michael.Hoffman@abbvie.com
Mehrdad Kheiripour
Manager
Neurocrine Biosciences Inc
Process Design & Engineering
160 Convent Avenue
10031
Email: mkheiripour@neurocrine.com
Papers:
Abstract Submissions Closed
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
